Our Scope of Work
1. Full medical translation and MTPE post-editing for pharmaceutical technical documents, clinical trial reports and medical research manuscripts
2. Independent Traditional Chinese localization for Hong Kong and Taiwan regions, adopting local medical terminology standards and eliminating cross-regional expression confusion
3. Accurate localization of drug instructions, dosage guidelines, contraindications and side-effect descriptions with zero tolerance for semantic deviation
4. Compliance optimization for pharmaceutical content to match local medical supervision regulations and regional publishing standards
5. Unified terminology management for drug names, medical mechanisms, treatment protocols and clinical indexes
6. Polishing of patient education materials and public medical copy to ensure professional yet easy-to-understand wording
7. Batch iterative editing for updated drug versions and revised clinical guidelines to maintain long-term project consistency

Project Challenge
Pharmaceutical localization is one of the highest-risk verticals in the translation industry. All medical data, dosage descriptions and clinical statements must be 100% accurate. Machine translation often produces ambiguous medical logic, confused drug terminology, and inconsistent dosage units, which may lead to serious safety risks. In addition, Hong Kong and Taiwan adopt different local medical glossaries and regulatory rules; simple character conversion will result in unqualified documents that fail official reviews. Furthermore, medical projects require extreme rigor, leaving no room for casual rewriting or colloquial expression, while frequent document updates demand both high efficiency and stable quality control.

Our Solution & Strength
LocTranslation set up a dedicated pharmaceutical localization team composed of native Traditional Chinese linguists and editors with medical industry backgrounds. We established two independent medical term banks and style guides for Taiwan and Hong Kong markets, strictly following local pharmaceutical industry specifications to replace inappropriate generic expressions and machine-generated errors.
Different from regular commercial translation, we implemented a double-review medical workflow. All core clinical content and drug specification texts undergo primary MTPE polishing and secondary professional medical verification to eliminate semantic errors and logical flaws. We never over-rewrite professional medical statements or use casual slang, ensuring every description complies with medical rigor. For iterative updated documents, our team maintains cross-version consistency to avoid term chaos caused by long-term project iteration.

Project Outcome
All localized pharmaceutical documents and medical materials successfully passed regional compliance audits and official market filing standards in Hong Kong and Taiwan. The unified medical terminology and standardized localized content supported Eli Lilly’s stable regional product launch and clinical promotion. This high-standard medical localization project fully demonstrates LocTranslation’s capability in handling high-precision, high-compliance industrial projects, proving our reliability for top global pharmaceutical enterprise cooperation.